NasdaqGS:INCYBiotechs
Assessing Incyte (INCY) Valuation As Short Term Returns Soften But Longer Term Gains Remain Strong
Incyte (INCY) has been drawing fresh attention after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months that contrast with its stronger longer term record.
See our latest analysis for Incyte.
At the latest share price of US$94.22, Incyte’s recent share price returns over 1 day, 7 days and 3 months have been weak, yet the 1 year total shareholder return of 57.03% and 3 year total shareholder return of 28.21% point to momentum that has...